Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.01SPGP 1.22ZUQ.TO 1.43NVDA 7GL 2.22MRK -4.11IEMG 1.85GEV 39.24
Patheon (PTI.TO)

Patheon (PTI.TO)

0.00
-0.00 (0.00%)
6 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
HOLD

Patheon(PTI.TO)

Dec 12, 2003
Well-run. In a space that is fairly predictable. Right now, a little tougher slugging in the pharmaceutical industry. Made some acquisitions that they are putting together. Could have some downside.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. Sc
Owned
Unlock Rating
$13.40

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
BUY

Patheon(PTI.TO)

Dec 04, 2003
Well-run. Good balance sheet. A buy-and-hold style of stock.
Photo of Peter HodsonPeter HodsonUnlock Rating
$13.46

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Nov 26, 2003
A show me situation. We'll be reporting in two or three weeks and is hoping to see a better quarter. Smart management.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$13.44

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Nov 11, 2003
(Top pick Sept 11/03. Down 5.7%.) Feels this is one of the premier manufacturers in the industry. Current multiples are quite reasonable. Have real earnings. Good price. Would add to their position on any pullback.
Photo of Michael SprungMichael Sprung
Owned
Unlock Rating
$13.55

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Oct 08, 2003
Stock has been beat up because the order backlog has not been as large as the market would like. Was oversold, so is a good value play. A strong company and they benefit from a strong Euro.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$13.35

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Patheon(PTI.TO)

Oct 07, 2003
Stuck in the $13/16 range. There has not been a lot of strength in the general outsourcers. They have a good business model and will grow over time. Have to be patient for the long-term.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$13.60

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Sep 29, 2003
Market didn't like their last earnings report so the stock dropped. Well-managed. A good buying opportunity.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$13.90

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Sep 25, 2003
Have real positive earnings. A well-run company. Book value is in excess of $5. It will earn $.55 this year and $.65 next year.
Photo of Michael SprungMichael Sprung
Owned
Unlock Rating
$14.18

Stock price when the opinion was issued

biotechnologypharmaceutical
Track your Stocks in your Watch List
TOP PICK

Patheon(PTI.TO)

Sep 11, 2003
A leader in their sector. Have real earnings.
Photo of Michael SprungMichael Sprung
Owned
Unlock Rating
$14.31

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Sep 04, 2003
Didn’t think the reported earnings were too bad. A little concerned about the growth going forward. There are a couple of big contracts that are coming to an end. A very good company.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$34.45

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Aug 19, 2003
Has a great track record.Has good growth opportunities.Also demographics are right.
Photo of Mike WeirMike Weir
Owned
Unlock Rating
$15.40

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Jul 08, 2003
(Was a top pick on Apr 4/03. Up 16%.) Still likes. Expects drug companies will do more sourcing out.
Photo of David BaskinDavid BaskinUnlock Rating
$15.10

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Jun 24, 2003
(Was a top pick on Apr 17/03. Up 15%.) Still likes and would add more if it dropped to $15.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. Sc
Owned
Unlock Rating
$15.15

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

May 20, 2003
(Was a top pick on Sept 12/02. Up 9.2%.) Had bought this under $10 and sold out over $15. Fully valued now.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$14.00

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Apr 17, 2003
Dependable business. Nice business model. Fear of being squeezed for thinner margins knocked the price of the stock down. Getting pretty good value in the $13 range. Good long term growth prospects.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$13.50

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 106 to 120 of 194 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.695$36.555
ET -0.165$18.905
MAIR 0$
RKLB 6.825$109.215
SESG-O 0$

Today's Top Picks

HMP.TO 0.01$9.76
SPGP 1.22$121.61
ZUQ.TO 1.43$108.9
NVDA 7$212.19
GL 2.22$168.98

Popular Articles

Latest Sell Signals

PRGO -0.255$10.735
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica